Organisation paid for research Program year 2025 Source: CMS Open Payments

St John Health System Inc

Neither a doctor nor a teaching hospital

Research payments

$1,158,157

267 payments

Through program year 2025, St John Health System Inc is reported as receiving $1,158,157 in research payments, across 267 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $216,463 103
2024 Research $155,036 60
2023 Research $72,130 24
2022 Research $82,045 9
2021 Research $366,339 5
2020 Research $246,928 64
2019 Research $19,216 2

Breakdown

Who paid Research payments · program years 2019–2025
  1. Eli Lilly and Company $403,330 5 payments
  2. Abbott Laboratories $272,230 84 payments
  3. Regeneron Pharmaceuticals, Inc. $230,837 63 payments
  4. Lexicon Pharmaceuticals, Inc. $92,942 43 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $61,828 45 payments
  6. Boston Scientific Corporation $56,684 23 payments
  7. Amgen Inc. $40,307 4 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Randomized, Double Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Ly3819253 and Ly3832479 in Participants With Mild to Moderate Covid-19 Illness $250,080 2 payments
  2. An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19 $230,837 63 payments
  3. A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate Covid-19 Illness (Blaze-4) $153,250 3 payments
  4. A Study of TAK-330 for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation $61,828 45 payments
  5. Elegance $56,684 23 payments
  6. SONATA-HCM / Sotagliflozin / LX4211 $52,264 31 payments
  7. NCT06656364--Esprit BTK Post-Approval Study $48,530 9 payments
  8. LIFE-BTK (Pivotal Investigation of Safety and Efficacy of BRS Treatment-Below The Knee) Randomized Controlled Trial $41,478 17 payments
  9. Sonata-Hcm $40,678 12 payments
  10. LIFE-BTK Randomized Controlled Trial $40,561 9 payments
What the money was spent on Research payments · program years 2019–2025
  1. Patient care $28,061 7 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record